The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
JOUNCE THERAPEUTICS, INC. COM 481116101 26,616 3,048,780 SH   DFND 1,2,3 3,048,780 0 0
NEON THERAPEUTICS, INC. COM 64050Y100 11,495 9,741,636 SH   DFND 1,2,3 9,741,636 0 0
VOYAGER THERAPEUTICS, INC. COM 92915B106 89,157 6,391,176 SH   DFND 1,2,3 6,391,176 0 0
FULCRUM THERAPEUTICS, INC. COM 359616109 99,211 5,962,202 SH   DFND 1,2,3 5,962,202 0 0